ARCHIVES

DCT Board Okays Six Contract Recompetitions

This article is from The Cancer Letter archive.

Vol. 13 No. 41 | October 23, 1987

Download PDF Visit The Full Archive

Related Articles

AACR, NCCR Advocate Five-Year Plan to Reach $10 billion Annual Cancer Budget

April 30, 1999

Sharfstein To Leave FDA

January 7, 2011

DCT Advisors OK 4 Contract Concepts In Therapeutics

June 28, 1991

New Mexico CBCCP Charges Contracts Terminated for “Mundane Political, Economic” Factors

April 25, 1980

ACS Prostate Cancer Recommendations Move Forward

August 7, 1992

FDA Committee nixes Combination Guidelines, Okays New NDA Policy

January 21, 1977